Treatment for symptomatic melanoma brain metastases remains challenging, with limited efficacy from current standard immunotherapies like anti–PD-1 and anti-CTLA4.
Of Interest
Common Virus Improves Melanoma Treatment Response, Reduces Side Effects
A common virus carried by approximately half of adults worldwide may improve outcomes for melanoma patients receiving immunotherapy while also protecting against severe treatment-related side effects and limiting the spread, according to new research from the University of Oxford.
Looking Ahead: What’s on the Horizon in Advanced Melanoma
Emerging therapies and treatment approaches in melanoma
How a protein and immune patterns in melanoma offer clues to more personalised treatments
Melanoma is one of the most aggressive forms of skin cancer, arising from pigment-producing cells called melanocytes.